Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

被引：0
|
作者：
Arzu Soybilgic
Karen B Onel
Tammy Utset
Kenneth Alexander
Linda Wagner-Weiner
机构：
[1] University of Illinois,
[2] University of Chicago,undefined
来源：
Pediatric Rheumatology | / 11卷
关键词：
Human papillomavirus; Lupus; Safety; Immunogenicity; Pediatric; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years
    Soybilgic, Arzu
    Onel, Karen B.
    Utset, Tammy
    Alexander, Kenneth
    Wagner-Weiner, Linda
    PEDIATRIC RHEUMATOLOGY, 2013, 11
  • [2] The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus
    Dhar, J. Patricia
    Essenmacher, Lynnette
    Dhar, Renee
    Magee, Ardella
    Ager, Joel
    Sokol, Robert J.
    VACCINE, 2017, 35 (20) : 2642 - 2646
  • [3] Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients with Systemic Lupus Erythematosus
    Mok, Chi Chiu
    Chan, Pak To
    Ho, Ling Yin
    Yu, Ka Lung
    To, Chi Hung
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S220 - S221
  • [4] Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study
    Mok, Chi Chiu
    Ho, Ling Yin
    Fong, Lai Shan
    To, Chi Hung
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : 659 - 664
  • [5] Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine
    Garland, Suzanne M.
    Cheung, Tak-Hong
    McNeill, Shelly
    Petersen, Lone Kjeld
    Romaguera, Josefina
    Vazquez-Narvaez, Jorge
    Bautista, Oliver
    Shields, Christine
    Vuocolo, Scott
    Luxembourg, Alain
    VACCINE, 2015, 33 (48) : 6855 - 6864
  • [6] Long-Term Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus
    Mok, Chi Chiu
    Ho, Ling Yin
    Fong, Lai Shan
    To, Chi Hung
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years
    Maldonado, Ivette
    Plata, Manuel
    Gonzalez, Mauricio
    Correa, Alfonso
    Nossa, Claudia
    Giuliano, Anna R.
    Joura, Elmar A.
    Ferenczy, Alex
    Ronnett, Brigitte M.
    Stoler, Mark H.
    Zhou, Hao Jin
    Joshi, Amita
    Das, Rituparna
    Bautista, Oliver
    Group, Thomas
    Luxembourg, Alain
    Saah, Alfred
    Buchwald, Ulrike Kirsten
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [8] Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus
    Mok, C. C.
    Ho, L. Y.
    To, C. H.
    VACCINE, 2018, 36 (23) : 3301 - 3307
  • [9] Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis -: Safety and immunogenicity
    Del Porto, F
    Laganà, B
    Biselli, R
    Donatelli, I
    Campitelli, L
    Nisini, R
    Cardelli, P
    Rossi, F
    D'Amelio, R
    VACCINE, 2006, 24 (16) : 3217 - 3223
  • [10] Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
    Sharma, Hitt
    Parekh, Sameer
    Pujari, Pramod
    Shewale, Sunil
    Desai, Shivani
    Bhatla, Neerja
    Joshi, Smita
    Pimple, Sharmila
    Kawade, Anand
    Balasubramani, Latha
    Thomas, Anitha
    Suri, Vanita
    Lalwani, Sanjay
    Uday, Rajini
    Kamath, Veena
    Mandal, Ranajit
    Rajeswar, A.
    Peedicayil, Abraham
    Poli, Usha Rani
    Banerjee, Dipanwita
    Sankaranarayanan, Rengaswamy
    Basu, Partha
    Muwonge, Richard
    Gairola, Sunil
    Dogar, Vikas
    Rao, Harish
    Shaligram, Umesh
    LANCET ONCOLOGY, 2023, 24 (12): : 1321 - 1333
12345